Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

THURSDAY, May 30, 2024-- Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel...